Natural history of the C282Y homozygote for the hemochromatosis gene (HFE) with a normal serum ferritin level

Clinical Gastroenterology and Hepatology

Volumn 1, Issue 5, 2003, Pages 388-391

  Yamashita, Cory ^a   Adams, Paul C ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; GENE; GENE MUTATION; HEMOCHROMATOSIS; HEMOCHROMATOSIS GENE; HOMOZYGOTE; HUMAN; MALE; MASS SCREENING; MEDICAL EXAMINATION; PEDIGREE ANALYSIS; TIME;

EID: 0141961623     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1053/S1542-3565(03)00187-3     Document Type: Article

References (12)

1. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang I, Prass C, Quintana L, Starnes S, Schatzman R, Brunke K, Drayna D, Risch N, Bacon B, Wolff R. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nature Genet 1996;13:399-408.
2. Adams PC, Chakrabarti S. Genotypic/phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria. Gastroenterology 1998;114:319-323.
3. Olynyk J, Cullen D, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999;341:718-724.
4. Beutler E, Felitti V, Koziol J, Ho N, Gelbart T. Penetrance of the 845G to A (C282Y) HFE hereditary hemochromatosis mutation. Lancet 2002;359:211-218.
5. Asberg A, Hveem K, Thorstensen K, Ellekjaer E, Kannelonning K, Fjosne U, Halvorsen T, Smethurst H, Sagen E, Bjerve K. Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol 2001:1108-1115.
6. Adams PC. Non-expressing C282Y homozygotes for hemochromatosis: minority or majority of cases? Mol Genet Metab 2000; 71:81-86.
7. McLaren C, Barton J, Adams P, Harris E, Acton R, Press N, Reboussin D, McLaren G, Sholinsky P, Walker A, Gordeuk V, Leiendecker-Foster C, Dawkins F, Eckfeldt J, Mellen B, Speechley M, Thomson E. Hemochromatosis and iron overload screening (HEIRS) study design for an evaluation of 100,000 primary care-based adults. Am J Med Sci 2003;325:53-62.
8. Adams PC, Kertesz AE, McLaren C, Barr R, Bamford A, Chakrabarti S. Population screening for hemochromatosis: a comparison of unbound iron binding capacity, transferrin saturation and C282Y genotyping in 5,211 voluntary blood donors. Hepatology 2000;31:1160-1164.
9. Barton J, Preston B, McDonnell S, Rothenberg B. Severity of iron overload in hemochromatosis: effect of volunteer blood donation before diagnosis. Transfusion 2001;41:123-125.
10. Lee P, Gelbart T, West C, Halloran C, Felitti V, Beutler E. A study of genes that may modulate the expression of hereditary hemochromatosis: transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins IRP1 and 2, and hepcidin. Blood Cells Mol Dis 2001;27:783-802.
11. Levy JE, Montross LK, Andrews NC. Genes that modify the hemochromatosis phenotype in mice. J Clin Invest 2000;105:1209-1216.
12. Adams PC, Alanen K, Preshaw R, Chakrabarti S, Jeffrey G, Howson W, Grant D. Transplantation of haemochromatosis liver and intestine into a normal recipient. Gut 1999;45:783.